Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Human medicine
Name of medicinal product: ABILIFY MAINTENA
Active substances:
Aripiprazole
Estonian, English, Latin
ATC code: N05AX12
Dosage form: powder and solvent for prolonged-release suspension for injection
Strength: 400mg
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Labelling:  
Indication: ABILIFY MAINTENA is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.
Safety features: Yes
Marketing authorization holder: Otsuka Pharmaceutical Netherlands B.V. 
Marketing authorization number: EU/1/13/882 
Marketing authorization issued on: November 15, 2013 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Centralised 
Assessment report:   
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1633373  ABILIFY MAINTENA  powder and solvent for prolonged-release suspension for injection  400mg 1TK  Prescription      13.03.2024    lahusti 2 ml 
1633384  ABILIFY MAINTENA  powder and solvent for prolonged-release suspension for injection  400mg 3TK  Prescription          lahusti 2 ml 
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere